The UK’s BioIndustry Association (BIA) has appointed Harren Jhoti, CEO of Astex Pharmaceuticals, and Will West, CEO of CellCentric, to its board of directors.
They take over from Andrew Heath, managing director of Morvus, and Dominique Kleyn, CEO of London Genetics, who will stand down at the end of 2012.
The BIA, which represents the country’s bioscience industry, also re-appointed Allan Marchington, partner at Apposite Capital, to the board.
All appointments will serve from January 1, 2013, for a term of two years.
Tim Edwards, BIA chairman, said: “As a result of these appointments, I believe our board continues to broaden its outlook and experience, and I look forward to working with them and the BIA team to ensure the UK remains a world-leading location for the life sciences.”